Financial Year |
March 31 2023 |
Monetary Funds |
63,670,007.82 |
Held-for-trading Financial Assets |
24,807,199.99 |
Notes Receivable |
612,208.92 |
Accounts Receivable |
1,261,173,728.52 |
Advances to Suppliers |
121,469,401.21 |
Other Receivables |
357,866,461.67 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
688,519,763.42 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
25,855,468.09 |
Other Current Assets |
89,514,832.60 |
Total Current Assets |
4,788,045,828.39 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
62,473,678.07 |
Long-term Equity Investment |
8,604,310.96 |
Investment Properties |
-- |
Fixed Assetes |
267,008,848.01 |
Under-construction Projects |
3,663,510.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
353,941,154.49 |
R&D expenses |
-- |
Goodwill |
414,056,885.20 |
Long-Term Deferred and Prepaid Expenses |
12,650,728.09 |
Deferred Income Tax Assets |
33,744,910.85 |
Other Non-Current Assets |
381,190,913.39 |
Sub-Total of Non-Current Assets |
2,881,152,227.29 |
Total Assets |
7,669,198,055.68 |
Short-Term Loans |
1,337,758,841.14 |
Trading Financial liabilities |
-- |
Notes Payable |
3,719,490.55 |
Accounts Payable |
1,948,254,006.98 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
113,210,855.54 |
Taxes Payable |
111,197,786.24 |
Interest Payable |
799,491,620.20 |
Dividend Payable |
-- |
Other payables |
2,556,185,835.69 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
300,935,237.16 |
Other Current Liabilities |
304,348,424.09 |
Sub-Total of Current Liabilities |
7,331,331,686.27 |
Long-term Loans |
554,508,562.61 |
Bonds Payable |
136,050,000.00 |
Long-Term Accounts Payable |
58,000,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
17,449,748.12 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
836,532,354.03 |
Total Liabilities |
8,167,864,040.30 |
Paid-In Capital(Or Share Stock) |
1,023,667,816.00 |
Capital Surplus |
4,169,053,103.01 |
Surplus Reserve |
30,351,919.86 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-5,735,096,351.53 |
Minority Stockholder's Interest |
103,029,050.92 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-601,695,035.54 |
Owner's Equity(Stockholder's Equity) |
-498,665,984.62 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,669,198,055.68 |